![]() |
Name |
isocromophilone F
|
Molecular Formula | C24H27ClO6 | |
IUPAC Name* |
8-chloro-11-(3,5-dimethylhepta-1,3-dienyl)-2-hydroxy-3-(1-hydroxyethylidene)-6-methyl-4-methylidene-5,12,14-trioxatetracyclo[7.5.0.01,13.02,6]tetradeca-8,10-dien-7-one
|
|
SMILES |
C=C1OC2(C)C(=O)C(Cl)=C3C=C(C=CC(C)=CC(C)CC)OC4OC34C2(O)C1=C(C)O
|
|
InChI |
InChI=1S/C24H27ClO6/c1-7-12(2)10-13(3)8-9-16-11-17-19(25)20(27)22(6)24(28,23(17)21(29-16)31-23)18(14(4)26)15(5)30-22/h8-12,21,26,28H,5,7H2,1-4,6H3/b9-8+,13-10+,18-14+/t12-,21+,22-,23+,24+/m0/s1
|
|
InChIKey |
ORFKRRJVUMRDKZ-BZKCTLPLSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 446.93 | ALogp: | 4.5 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 88.5 | Aromatic Rings: | 4 |
Heavy Atoms: | 31 | QED Weighted: | 0.359 |
Caco-2 Permeability: | -4.714 | MDCK Permeability: | 0.00001600 |
Pgp-inhibitor: | 0.979 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.919 |
30% Bioavailability (F30%): | 0.019 |
Blood-Brain-Barrier Penetration (BBB): | 0.615 | Plasma Protein Binding (PPB): | 88.06% |
Volume Distribution (VD): | 2.828 | Fu: | 5.85% |
CYP1A2-inhibitor: | 0.119 | CYP1A2-substrate: | 0.781 |
CYP2C19-inhibitor: | 0.846 | CYP2C19-substrate: | 0.883 |
CYP2C9-inhibitor: | 0.589 | CYP2C9-substrate: | 0.015 |
CYP2D6-inhibitor: | 0.306 | CYP2D6-substrate: | 0.086 |
CYP3A4-inhibitor: | 0.917 | CYP3A4-substrate: | 0.927 |
Clearance (CL): | 4.144 | Half-life (T1/2): | 0.05 |
hERG Blockers: | 0.206 | Human Hepatotoxicity (H-HT): | 0.967 |
Drug-inuced Liver Injury (DILI): | 0.91 | AMES Toxicity: | 0.938 |
Rat Oral Acute Toxicity: | 0.959 | Maximum Recommended Daily Dose: | 0.917 |
Skin Sensitization: | 0.904 | Carcinogencity: | 0.923 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.955 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001876 | ![]() |
0.455 | D05QDC | ![]() |
0.205 | ||
ENC002178 | ![]() |
0.449 | D0B1IP | ![]() |
0.195 | ||
ENC001875 | ![]() |
0.441 | D0G3PI | ![]() |
0.193 | ||
ENC001877 | ![]() |
0.435 | D00DKK | ![]() |
0.193 | ||
ENC001871 | ![]() |
0.435 | D02DGU | ![]() |
0.193 | ||
ENC002010 | ![]() |
0.425 | D0S7WX | ![]() |
0.186 | ||
ENC001841 | ![]() |
0.422 | D0WY9N | ![]() |
0.171 | ||
ENC004682 | ![]() |
0.400 | D0E9KA | ![]() |
0.170 | ||
ENC005594 | ![]() |
0.395 | D0H6VY | ![]() |
0.167 | ||
ENC005595 | ![]() |
0.386 | D0C1SF | ![]() |
0.165 |